Radiofrequency Ablation for Lower Back Pain
Trial Summary
What is the purpose of this trial?
This trial tests two methods of using heat to destroy nerve tissue in patients with lower back pain from the sacroiliac joint. The goal is to see which method is better at reducing pain by stopping pain signals from reaching the brain.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking more than 50 mg of morphine-equivalent opioids per day, you may not be eligible to participate.
What data supports the effectiveness of this treatment for lower back pain?
Some studies suggest that radiofrequency ablation (RFA) can improve quality of life and manage pain in patients with sacroiliac joint (SIJ) dysfunction, although results have been inconsistent. The Simplicity III RF probe has shown promise as a novel treatment option, and some patients report increased satisfaction and improved quality of life after undergoing RFA.12345
Is radiofrequency ablation for lower back pain generally safe for humans?
How does radiofrequency ablation for lower back pain differ from other treatments?
Radiofrequency ablation (RFA) for lower back pain targets the lateral branches of the sacral nerves, which are variable in position, making it a unique approach compared to other treatments. The Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA) uses a novel probe that may offer more consistent results than traditional methods, addressing the variability in nerve anatomy.13458
Research Team
Eligibility Criteria
Adults aged 18-90 with lower back pain for at least 3 months, unresponsive to conservative treatments, and a pain level of at least 4/10. Participants must have experienced a minimum of 50% pain relief from specific diagnostic injections and be able to follow the study procedures in English.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA) or Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA) to treat sacroiliac joint pain
Follow-up
Participants are monitored for pain relief and functional improvement at 3, 6, 12, 18, and 24 months
Treatment Details
Interventions
- Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA) (Radiofrequency Ablation)
- Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA) (Radiofrequency Ablation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
Jeffrey Wilkins
University of Utah
Chief Medical Officer since 2022
MD from Meharry Medical College
Stephen Tullman
University of Utah
Chief Executive Officer since 2022
BS in Accounting from Rutgers University
Stratus Medical, INC
Collaborator